PACTR202108825067735尚未招募4 期
Calcium Aspirin Preeclampsia/ Eclampsia Early Prevention and Response Study
Preeclampsia Research Laboratories PEARLS Heart Research Institute0 个研究点目标入组 296 人开始时间: 2021年8月19日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 296
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13 Year(s) 至 18 Year(s)（—）
- 性别
- Female
入选标准
- •1All urban health centres providing maternal health services in Blantyre
- •2All Pregnant women screened and identified to be at risk of preeclampsia/ eclampsia such as those with:
- •Hypertensive disease during previous pregnancy
- •Chronic kidney disease
- •Type 1&2 diabetes
- •Chronic hypertension
- •Auto immune disease such as systematic lupus erythematosus or antiphospholipid syndrome
- •previous history of preeclampsia/eclampsia,
- •previous an explained abruption
- •advanced maternal/extreme of age, teenagers
- •3. Those with family history of eclampsia/preeclampsia, twin pregnancy, chronic hypertension, diabetes )
- •4. They should be between 11 to 16 weeks gestation
排除标准
- •1.All women with increased risk of bleeding due to coagulation disorders or placenta previa
- •2.Women who are allergic to aspirin or calcium
- •3.Women who are planning to deliver at another health facility
- •4.All women who did not consent
研究者
相似试验
招募中
1 期
Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology.Preeclampsia during pregnancyCTIS2022-500933-10-00Centre Hospitalier Universitaire De Toulouse1,164
尚未招募
不适用
To study the role of low dose Aspirin in prevention of PreeclampsiaCTRI/2019/05/019232Vss Institute of medical science and research
已完成
3 期
ow-dose aspirin in the prevention of preeclampsiaPreeclampsiaPregnancy and ChildbirthPre-eclampsiaISRCTN81414657Beacon Pharmaceuticals Ltd200
已完成
不适用
ow-dose aspirin for reduction in preeclampsia risk in high-risk women in Japan.preeclampsiaJPRN-UMIN000020013Osaka Medical Center and Research Institute for Maternal and Child Health600
进行中（未招募）
不适用
acetylcystein til gravide med præeklampsiPræeklampsi komplicerer ca. 2% af alle graviditeter og giver anledning til øget morbiditet og mortalitet for både moder og barn. Syndromet er karakteriseret ved hypertension og proteinuri og kompliceres ofte af yderligere organ-påvirkning.Symptomerne har baggrund i oxidativt stress, inflammation og endotheldysfunktion hos moderen.EUCTR2005-000289-38-DKOrganisation name was not entered30